Glaucoma is one of the leading causes of irreversible visual impairment and blindness in the developed countries 1 . The conventional regimens for glaucoma are based on surgical or medical interventions to reduce intraocular pressure and limit visual loss. However, in many patients, the number of retinal ganglion cells (RGCs) still degenerate progressively irrespective of treatment. Owing to the fact that RGCs and endogenous retinal progenitor cells have limited regenerative power to replace cell loss, new and effective therapies should be developed against these sight-threatening diseases. Recently, the incremental progress in stem cell research has shown promising applications of stem cells in therapeutic treatments.
leads to the establishment of various protocols on the induction of embryonic stem cells (ESCs) into retinal lineage [3] [4] [5] [6] . Similar induction capability also applies to induced pluripotent stem cells (iPSCs) 7 .
Retinal induction of adult stem cells have also been demonstrated 8, 9 . Previously, we reported that the human adult periodontal ligament-derived stem cells (PDLSCs) are capable of differentiating into the neurogenic, cardiomyogenic, chondrogenic and osteogenic lineages 10 . Recently, we successfully induced the PDLSCs to retinal fate, with the PDLSC-derived retinal cells expressing photoreceptor makers 11 . In this study, we modified the induction protocol to generate RGC-like cells with electrophysiological functions. Moreover, we hypothesized that the retinal induction of PDLSCs is governed by genetic and microRNA (miRNA) regulation. Up to date, the gene expression profile of retinal induction has only been reported using ESCs 12 , whereas the miRNA expression profiles only limited to the differentiation of ESCs and iPSCs into retinal pigment epithelial (RPE) cells [13] [14] [15] . Nevertheless, miR-125, miR-9 and let-7 have recently been shown to be the key regulators of the retinal progenitor development in mice 16 . The original retinal induction protocol which we adopted mainly produced Pax6 +
/Chx10
+ retinal progenitors and RGCs 5 . We, in this study, determined the RGC marker expression, the glutamate-induced calcium response as well as the electrophysiology of the differentiated PDLSCs. Moreover, the miRNA expression profile of retinal induction on human adult PDLSC was identified using microarray platform. In addition, the expression of predicted miRNA targets was also evaluated.
Results

Transdifferentiation of human PDLSCs into retinal ganglion-like cells. After retinal induction
( Fig. 1A) , human PDLSCs showed a neuron-like morphology when compared to the fibroblast-like morphology in control group (Fig. 1B) . During the retinal induction process of PDLSC, gene expression analysis showed time-dependent upregulation of retinal progenitor markers (PAX6 and VSX2) as well as RGC marker (ATOH7 and POU4F2) when compared to Day 0 undifferentiated PDLSC (Fig. 1C) . Similarly, retinal-induced PDLSC highly expressed retinal progenitor marker protein (PAX6 and CHX10) and mature RGC marker protein (POU4F2) after the retinal induction treatment (Fig. 1D) . Moreover, immunofluorescence signals of β -III tubulin, MAP2, TAU, POU4F2, NEUROD1 and SIX3 were also detected in the induced PDLSCs ( Fig. 2A) . 30-52% (mean = 40%) of the induced cells displayed the expression of these retinal and neuronal markers (Fig. 2B) . The induced PDLSCs could form synapses with neighboring cells as shown by the immunofluorescence signal of synaptophysin ( Fig. 2A) . In addition, the induced PDLSCs responded to 1 μ M glutamate exposure and showed elevated spontaneous calcium transients when compared to the control group in spike amplitude and intracellular calcium concentration (Fig. 3) . Furthermore, the induced PDLSCs could generate spontaneous spikes (Fig. 4) . The spike signal of the induced PDLSC was 21.24 ± 1.92 μ V with a frequency of 11 spikes per second, whereas that of purified neonatal rat RGCs was 39.27 ± 6.69 μ V with a frequency of 17 spikes per second. These electrical signals were not observed in the control group (peak signal = 9.58 ± 1.62 μ V), which was close to the background signal (7.07 ± 1.62 μ V; data not shown). These data suggested that our induced PDLSCs demonstrated functional neuronal activity. The transdifferentiation of PDLSCs were specific to the neuronal lineage as they were not induced to bone or adipose lineages by our retinal induction treatment, shown by the negative staining of alkaline phosphatase and Oil Red O, respectively (Supplementary Figure 1) . Collectively, these indicated that our newly modified noggin-Dkk1-IGF1 induction treatment can direct human PDLSCs into retinal ganglion-like cells, which also confirmed the retinal induction results from our previous report 11 .
The microRNA signatures of retinal-induced human PDLSCs. To understand the molecular mechanism of retinal induction effect, global miRNA expression profile (miRNome) of retinal-induced PDLSC was determined by microarray. The miRNA expression profiles of groups at Day 0 and Day 24 were differentially clustered and separated from each other by either hierarchical clustering (Fig. 5A ) or principle component analysis (Fig. 5B) . A total of 170 miRNAs were expressed at a two-fold difference in treated PDLSC at Day 24 compared to Day 0. Among these 170 miRNAs, 71 of them were differentially expressed (p corr < 0.05 and fold change > 2; Table 1 ). 44 of them were upregulated, and 27 of them were downregulated. Based on expression levels, the predicted miRNA target genes and reported neuron-related miRNA 17, 18 , 5 miRNAs (hsa-miR-132, hsa-miR-29b, hsa-miR-30d, hsa-miR-630 and hsa-miR-7) were selected for validation. hsa-miR-29b and hsa-miR-7 were downregulated throughout the treatment period (Fig. 6 ). In contrast, hsa-miR-132 and hsa-miR-630 were upregulated along the retinal induction treatment. These 4 miRNAs showed significant difference during the treatment period when compared to Day 0. However, hsa-miR-30d did not show significant fold-change differences. Therefore, 4 out of 5 selected miRNAs were validated. Notably, comparing to the reported miRNAs in eye and retinal progenitor development, RPE differentiation and retinal degeneration [13] [14] [15] [16] 19, 20 , 12 miRNAs showed p corr < 0.05 (hsa-let-7b
, hsa-let-7i, hsa-miR-125a-3p, hsa-miR-125a-5p, hsa-miR-15b, hsa-miR-181a, hsa-miR-18a, hsa-miR-214, and hsa-miR-301a; Table 2 ). Subsequently, a global target gene list of the retinal-induced miRNAs (2043 genes) was generated by the TargetScan in the GeneSpring (Agilent) platform. Gene ontology of this gene list, analyzed by DAVID (1942 DAVID identities), revealed that retinal-induced miRNAs might target the genes involved in different processes of neuron differentiation (Table 3) .
microRNA-132 in retinal progenitor cell differentiation and its target gene analysis in human PDLSCs. In order to delineate the biological roles of the differentially expressed miRNAs in retinal differentiation process, retinal progenitor cells from embryonic day 18 rats were transfected with an expression plasmid inserted with miR-132 precursor sequence and treated with differentiation medium. Compared to the empty vector control (pCMVMIR), downregulation of Pax6 gene (1.5 folds, p < 0.001) and upregulation of Brn3a and Brn3b genes (4.2 folds, p < 0.01 and 5.1 folds, p < 0.001, respectively) were observed in retinal progenitor cells transfected with miR-132 expression plasmid (Fig. 8A) . Rho and Gfap genes showed no significant difference between empty vector control and miR-132-transfected cells. The retinal progenitor cell differentiation analysis suggested that miR-132 could direct retinal progenitor cells towards RGC lineage.
Meanwhile, we performed the gene ontology analysis on the TargetScan-predicted miR-132 target genes (407 genes), and compared the gene lists related to neuron differentiation (62 genes) and negative regulation of cell differentiation (38 genes; Fig. 8B ). There are 15 genes in common, which are FGFR3, GSK3B, RORA, FOXP1, GATA2, NET1, NTN1, DPYSL3, PTCH1, DCC, ISL1, SOX4, SRGAP2, SALL1 and CUX1. Among these 15 genes, GSK3B, NET1, DPYSL3, SOX4, SRGAP2, and CUX1 showed moderate to strong expression in human PDLSCs, whereas RORA, GATA2 and SALL1 showed weak expression (data not shown). When human PDLSCs were transfected with miR-132 expression plasmid, the expression of CUX1 (cut-like homeobox 1) protein was reduced by 33% (p < 0.001; Fig. 8C ), suggesting that CUX1 gene could be a downstream target gene of miR-132.
Discussion
Stem cell therapy for retinal diseases has entered the stage of clinical trials. Autologous bone marrow-derived mononuclear cells have been applied in patients with retinitis pigmentosa or cone-rod dystrophy 23 . Moreover, human ESC-derived retinal pigment epithelial cells were used to treat patients with Stargardt's macular dystrophy and advanced non-exudative age-related macular degeneration by cell replacement therapy 24 . But adult stem cell-derived retinal cells have not been attempted for use in cell replacement therapy. We aim to study human adult stem cells as they can be conveniently obtained from patients for autologous transplantation or in vitro drug screening, which is the basis of personalized medicine in future. We made a progress in this direction when we induced human adult PDLSCs to retinal fate 11 . Results of this present study confirm the feasibility of retinal induction on human PDLSCs. We found PDLSCs underwent the noggin-Dkk1-IGF1 induction treatment not only produced photoreceptor cells as we have previously reported 11 , but also expressed RGC and neuronal markers (ATOH7, POU4F2, β -III tubulin, MAP2 and TAU; Figs 1 and 2), formed synapses, gave glutamate-induced calcium responses ( Fig. 3 ) and demonstrated spontaneous electrical activities (Fig. 4) in this study. The mechanism of this retinal induction process warrants further investigation. This study also, for the first time, reported the miRNA signatures of retinal induction on human adult stem cells. After 24-day retinal induction treatment, 71 human miRNAs were differentially expressed, which 44 of them were upregulated and 27 were downregulated (Table 1 ). Comparing to the reported miRNAs related to eye and retinal progenitor development, RPE differentiation and retinal degeneration [13] [14] [15] [16] 19, 20 , 12 miRNAs showed p corr < 0.05 ( Table 2 ). Six of them (hsa-let-7f-1, hsa-let-7i, hsa-miR-125a, hsa-miR-15b, hsa-miR-18a and hsa-miR-301a) were commonly found in the differentiation treatment of ESC into retinal pigment epithelial cells 13 . Moreover, let-7 and miR-125 families are key regulators of retinal progenitor cell development 16 . In addition, 17 miRNAs (miR-136, miR-143, miR-148a, miR-15b, miR-18a, miR-181a, miR-181a*, miR-20b, miR-27b, miR-29b, miR-30d, miR-30e*, miR-301a, miR-376a, miR-376b, miR-410 and miR-7), which are differentially expressed in our retinal induction treatment, are involved in the regulation of developing mouse retina 25 . Thus our miRNA profile is closely related to the retinal cells formation processes, indicating that the commonly found miRNAs may guide human PDLSCs to retinal precursors with a similar differentiation pathway as ESC and retinal development in mice.
Among the upregulated miRNAs, miR-132 is expressed in RGCs 26 and regulates neuron development and neurite morphology 17, 18 . In this study, we, for the first time, showed that miR-132 could be involved in the RGC differentiation from retinal progenitor cells as its overexpression in retinal progenitor cells upregulates mature RGC markers (Brn3a and Brn3b) expression (Fig. 8A ). This further confirms that miR-132 contributes to the differentiation of human PDLSCs into retinal ganglion-like cells. Moreover, we also demonstrated that miR-132 could downregulate CUX1 protein expression in human PDLSCs (Fig. 8C ). Since reduction in Cux1 expression has been shown to promote neurite outgrowth in cortical neurons 27 , the morphology of human PDLSC-derived neurons could be related to the interactive functions of miR-132 and CUX1 in our trans-differentiation process. In addition, the properties of miR-132 are consistent with the gene ontology analysis of the predicted miRNA target genes (Table 3) . Furthermore, BDNF and bFGF were suggested to induce miR-132 expression 28, 29 , indicating that BDNF and bFGF in our treatment medium might be responsible for the upregulation of miR-132 in the induced PDLSCs. Notably, the highest upregulated miRNA, hsa-miR-630, was correlated with cancer cell death 30, 31 . This is the first report that it could be associated with neuronal differentiation of human adult stem cells. In addition, GJA1, which is a negative modulator of neuronal differentiation 32 , was downregulated along the retinal induction period (Fig. 7) , further affirming our PDLSC proceed towards neuronal differentiation under the retinal induction treatment.
We chose the 5 miRNAs (hsa-miR-132, hsa-miR-29b, hsa-miR-30d, hsa-miR-630 and hsa-miR-7) for validation not just based on the previous reports or the expression levels, but also the predicted target genes. VEGFA is the target gene of hsa-miR-29b and hsa-miR-15b (Supplementary Table 2 ), which were downregulated during the retinal induction treatment (Table 1 and Fig. 6 ). From miRNA target expression analyses, we found that VEGFA gene expression, VEGF protein expression and VEGF 165 secretion were all increased (Fig. 7) . These findings verify the prediction that VEGFA upregulation could be correlated with hsa-miR-29b and hsa-miR-15b downregulation. Furthermore, hypoxia, which upregulates VEGF, has been shown to increase retinogenesis from ESC 33 . Therefore, the elevated VEGF level, together with downregulation of hsa-miR-29b and hsa-miR-15b, should account for retinal differentiation of human adult stem cells.
Our retinal induction protocol produces retinal ganglion-like cells (Figs 1-4) . The selected target genes (KLF4, MAP3K12, PTEN and SOCS3) are closely related to RGCs for gene expression analysis 21, 22, 34 . MAP3K12, PTEN and SOCS3 genes as well as the PTEN protein were upregulated during the retinal induction process (Fig. 7) . Since deletion of Pten at the onset of neurogenesis in retinal progenitor cells results in the reduction of RGCs and rod photoreceptors 35 , our results further suggest that the treated PDLSC undergo proper retinal/neuronal differentiation guided by PTEN regulation. Moreover, KLF4, the predicted target of hsa-miR-7 (Supplementary Table 3) , was upregulated during the retinal induction treatment (Fig. 7) . Accordingly, KLF4 could also participate in RGC development during PDLSC retinal differentiation 34 . Nevertheless, we predicted that KLF4 upregulation could be correlated with hsa-miR-7 downregulation (Figs 6 and 7) , which is confirmed by a recent study on neural stem cell differentiation 36 . In-depth functional analyses as well as the relationship with putative target genes are needed to validate the role of miRNAs in retinal induction process of human adult stem cells. In summary, this study, for the first time, demonstrated transdifferentiation of human PDLSCs into functional retinal ganglion-like cells, and identified miR-132, VEGF and PTEN as key regulators in the retinal fate determination of human adult stem cells. Results from this study reveal the involvements of both genetics and miRNA regulatory mechanisms in human adult stem cell retinal differentiation.
Methods
Human periodontal ligament-derived stem cell culture. Human PDLSC lines were established previously 10, 11 . These cells were cultured in Dulbecco's modified Eagle's medium (high glucose; Gibco BRL, Rockville, MD) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco BRL). Cells with passage 3-5 were used for the retinal induction experiments.
Retinal induction. Human PDLSCs were induced by a previously established retinal induction protocol 5,11 with modification (Fig. 1A) . Briefly, PDLSCs (200 cells/μ l) were first treated with 10% knockout serum replacement (Gibco BRL), 1x B27 supplement (Gibco BRL), 1 ng/ml noggin (PeproTech, Rocky Hill, NJ), 1 ng/ml dickkopf-related protein 1 (Dkk-1; PeproTech) and 5 ng/ml insulin-like growth factor 1 (IGF-1; PeproTech) in Dulbecco's modified Eagle's medium: nutrient mixture F-12 (DMEM/F12; Gibco BRL) at low adherent culture for 3 days. After 3 days, the cell aggregates were transferred to the dishes coated with laminin (Sigma-Aldrich, St. Louis, MO) and treated with 1x B27 supplement, 1x N2 supplement (Gibco BRL), 100 ng/ml noggin, 10 ng/ml Dkk-1, 100 ng/ml IGF-1 and 50 ng/ml basic fibroblast growth factor (bFGF; PeproTech) in DMEM/F12 medium for 7 days. The culture medium was then switched to 1x B27 supplement, 1x insulin-transferin-selenium supplement (Gibco BRL), 10 ng/ml noggin, 10 ng/ml Dkk-1, 10 ng/ml IGF-1, 50 ng/ml bFGF, 10 ng/ml brain-derived neurotrophic factor (BDNF; PeproTech), 10 ng/ml ciliary neurotrophic factor (CNTF; PeproTech), 10 ng/ml nerve growth factor (NGF; PeproTech) and 10 ng/ml sonic hedgehog (Shh; PeproTech) in DMEM/F12 medium and further treated for 14 days. Culture medium was changed every 3 days. The control medium was the DMEM/F12 medium supplemented with 10% FBS. Culture supernatant, total RNA and cell extracts from the culture cells were collected at Day 0, 10, 17 and 24 for further analyses.
Glutamate-evoked calcium response. Spontaneous intracellular calcium transient was evaluated
using fluo-4-acetoxymethyl ester (Fluo-4AM; Invitrogen) 11 . Briefly, the treated or control PDLSCs at Day 24 were incubated in Hanks' balanced salt solution (HBSS, Ca 5μ M Fluo-4AM and 0.1% pluronic F-127 (Sigma-Aldrich) for 30 minutes at room temperature. After washing with HBSS, 1 μ M glutamate (Sigma-Aldrich) was added to the culture, and fluorescence images were immediately captured using a fluorescence microscope (Eclipse Ni-C; Nikon, Japan), with excitation wavelength at 495 nm and emission wavelength at 515 nm, every 5 seconds for a total of 2 minutes under a 40X objective lens. Fluorescence intensity at specific time intervals was measured on a total of 50 cells in triplicate experiments (at least 10 cells in each sample) by the NIS-Element AR software (Nikon).
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The cellular change of fluorescence (F; %Δ F/F baseline ) of each region was calculated as (F treated -F baseline )/ F baseline X 100%. The Ca 2+ fluorescence ratio was converted into Ca 2+ concentration using the equation 37 , where K is the dissociation constant of Fluo-4AM (400 nM), R is the fluorescence ratio (Δ F/F baseline ) and [Ca 2+ ] rest is the resting Ca 2+ concentration (100 nM in neuronal cells) 38 .
Electrical activity analysis. Spontaneous electrical activities of the induced PDLSCs were detected by a microelectrode array (MEA) system (Multi Channel Systems, Reutlingen, Germany) on a laminin-coated 54-electrode 6-well MEA chip at Day 24 of differentiation. The differentiated cells were seeded onto the MEA chip at least 7 days prior to recording. The MEA signals, sampled at 25 mHz for 200 seconds, were amplified and digitized using the MEA-2100-60 system (Multi Channel Systems) with integrated temperature controller, data acquisition interface. The spike events were then filtered and analyzed using the MCRack software (Multi Channel Systems). The field potentials where electrodes exhibiting spike frequencies below 0.1 Hz were removed by a 0.1 Hz High Pass filter based on reported minimal steady firing rates 39 . Spikes were detected after spike sorting at a threshold of 15 μ V
40
. The MEA signal of purified neonatal RGCs was used as a reference.
microRNA microarray and data analysis. The protocol for microRNA microarray analysis has been established previously 41 . Briefly, total RNA, including the miRNA fraction, in TRIzol reagent was 42 . Enrichment score greater than 1.3 was considered as significant. Based on expression levels, the predicted miRNA target genes and reported neuron-related miRNA 17, 18 , 5 miRNAs from microarray results (hsa-miR-132, hsa-miR-29b, hsa-miR-30d, hsa-miR-630 and hsa-miR-7) were selected for validation. Total RNA (20 ng) was reverse transcribed using the TaqMan MicroRNA Reverse Transcriptase kit (Applied Biosystems, Forster City, CA). The resultant products were quantified using the appropriate TaqMan MicroRNA Assays (Applied Biosystems) on a Stratagene Mx3005P Real-Time PCR Detection System (Stratagene, La Jolla, CA). Results were all normalized to U6 expression. Independent T-test was used for statistical analysis. Three independent samples from each time-point were used in the validation experiment.
Gene and protein expression analyses. To validate our retinal induction on PDLSC producing RGCs, retinal progenitor (PAX6, VSX2/Chx10), RGC (ATOH7 and POU4F2) and neuronal (TAU, MAP2, β -III tubulin, NEUROD1 and SIX3) marker expression as well as synapse formation analysis (synaptophysin) were performed by semi-quantitative PCR with specific primers (Supplementary Table  1) , immunoblotting or immunofluorescence analysis with specific antibodies (Supplementary Table 2 ). The predicted miRNA target genes related to eye development or neuron differentiation (GJA1, KLF4, MAP3K12, PTEN, SOCS3 and VEGFA) were also examined.
For gene expression analysis of the predicted miRNA target genes, Sybr green PCR (Applied Biosystems) was performed on a real-time PCR machine (Stratagene, La Jolla, CA). Housekeeping gene (GAPDH) was used for normalization. The relative expression levels were compared to that of Day 0.
For immunoblotting analysis, the induced PDLSCs were lysed by RIPA buffer supplemented with protease and phosphatase inhibitors. The total protein concentrations of the cell lysates were measured by Protein assay (BioRad, Hercules, CA). Equal amount of total protein (10 μ g) for each denatured samples were resolved on 12.5% SDS-polyacrylamide gel and electro-transferred to nitrocellulose membranes for sequential probing with the primary antibodies and secondary antibodies conjugated with horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA). The signals were detected by enhanced chemiluminescence (Amersham Pharmacia, Cleveland, OH) with the ChemiDoc TM XRS + system (BioRad). β -actin was used as housekeeping protein for normalization.
For immunofluorescence analysis, the induced PDLSCs were fixed in 4% paraformaldehyde (Sigma Aldrich, St. Louis, MO). After permeation and blocking, the cells were labeled with different primary antibodies against RGC or neuronal markers and secondary antibodies conjugated with Alexa Fluor ® 488 or 594 (Santa Cruz Biotechnology). DAPI was used for the nuclear staining. The fluorescence signals were visualized under a fluorescence microscope (Eclipse Ni-U; Nikon).
VEGF 165 secretion was analyzed by ELISA assay. Briefly, culture supernatant was concentrated by a 3-kDa centrifugal filtration unit (Millipore, Billerica, MA), and total protein concentration was measured by Protein assay (BioRad). Equal amount of total protein (1 ng) was applied to the human VEGF Quantikine ® ELISA assay (R&D Systems Inc., Minneapolis, MN) according to the manufacturer's protocol. Absorbance at 450 nm with a reference of 540 nm was measured by a spectrophotometer (Powerwave XS, Bio-Tek Instruments). The amount of VEGF 165 secreted to the culture supernatant (pg of VEGF 165 /ng of total protein in culture supernatant) were then determined.
Retinal progenitor cell differentiation. Retinas from embryonic day 18 Sprague Dawley rats were digested with 0.05% trypsin (Gibco BRL) for 5 min. The retinal cells were dissociated by repeat pipetting in 1 mg/ml trypsin inhibitor (Sigma-Aldrich). Single cells were collected by passing through the 40 μ m cell strainer and cultured in the low adherent dish with Neurobasal A medium (Gibco BRL) supplemented with 1 × N2 (Gibco BRL), 1% bovine serum albumin (Sigma-Aldrich), 20 nM progesterone (Sigma-Aldrich), 20 ng/ml bFGF (PeproTech), 30 ng/ml epidermal growth factor (EGF; PeproTech) and 2 μ g/ml heparin (Sigma-Aldrich) for 3 days. Neurospheres were collected, transfected with miR-132 expression plasmid (OriGene, Rockville, MD) and cultured in the differentiation medium (Neurobasal A medium with 1x B27) for 7 days. RNA of the differentiated cells was collected and isolated as previously mentioned. Expression analysis on Pax6, Brn3a, Brn3b, Rho and Gfap genes was performed by Sybr green PCR with specific primers (Supplementary Table 1 
